In honor of World Blindness Awareness Month, "GMA" is spotlighting a breakthrough gene therapy that's helping some blind ...
The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...
A 3-year-old girl who underwent a breakthrough gene therapy treatment to treat profound hearing loss can hear on her own, two years after the treatment.
UniQure's therapy, called AMT-130, reduced disease progression by 75% at 36 months in patients who received a high dose.
The Chosun Ilbo on MSN
FDA Speeds Up Custom Gene Therapy Approvals With Existing Data
Last May, people were thrilled to learn that a 7-month-old baby who became the first in the world to receive a personalized ...
Researchers announce breakthrough results for AMT-130, the first disease-modifying treatment for Huntington's disease, with ...
In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
The FDA has officially placed two of Intellia’s Phase III studies under clinical hold after the biotech reported earlier this ...
DURHAM, N.C. (WTVD) -- Duke Eye Center has become the first academic medical center in the country to implant a new cell-based gene therapy for a rare eye disease called MacTel. This procedure offers ...
Oncologists' experience with CGT has increased, with more patients treated and earlier lines of therapy being utilized.
Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...
BioMarin no longer expects to hit its $4 billion revenue target by 2027, citing various market factors such as impending ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback